Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China · Delayed Price · Currency is CNY 12.63
+0.35 (2.85%)
Oct 23, 2026, 3:04 PM CST
SHE:300401 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 1,293 | 1,032 | 1,284 | 1,503 | 554.91 | 502.09 |
Trading Asset Securities | 90.26 | 301.22 | 140.25 | - | - | 0.4 |
Cash & Short-Term Investments | 1,383 | 1,334 | 1,425 | 1,503 | 554.91 | 502.49 |
Cash Growth | -10.29% | -6.39% | -5.20% | 170.83% | 10.43% | -63.08% |
Accounts Receivable | 179.5 | 234.9 | 157.74 | 92.78 | 169.66 | 90.46 |
Other Receivables | 1.38 | 15.31 | 0.73 | 0.8 | 1.21 | 0.41 |
Receivables | 180.88 | 250.21 | 158.47 | 93.57 | 170.87 | 90.87 |
Inventory | 797.51 | 750.08 | 838.23 | 780.04 | 545.87 | 429.94 |
Other Current Assets | 87.03 | 82.4 | 47.99 | 85.56 | 115.37 | 88.07 |
Total Current Assets | 2,448 | 2,416 | 2,469 | 2,462 | 1,387 | 1,111 |
Property, Plant & Equipment | 3,092 | 2,992 | 2,787 | 2,455 | 2,432 | 2,119 |
Other Intangible Assets | 234.9 | 213.87 | 182.73 | 172.23 | 165.77 | 165.87 |
Long-Term Accounts Receivable | - | - | 0.03 | - | - | - |
Long-Term Deferred Tax Assets | 50.4 | 35.64 | 36.27 | 40.41 | 19.76 | 11.51 |
Long-Term Deferred Charges | 48.15 | 57.72 | 26.52 | 24.52 | 25.46 | 16.61 |
Other Long-Term Assets | 82.38 | 66.53 | 110.86 | 106.01 | 101.97 | 105.67 |
Total Assets | 5,956 | 5,782 | 5,613 | 5,261 | 4,132 | 3,530 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 298.59 | 328.88 | 340.54 | 327.87 | 443.02 | 329.59 |
Accrued Expenses | 27.45 | 67.69 | 63.14 | 50.42 | 60.83 | 47.21 |
Short-Term Debt | 432.36 | 431.4 | 462.79 | 408.68 | 532.39 | 414.37 |
Current Portion of Long-Term Debt | - | 60.03 | 198.16 | 254.51 | - | - |
Current Portion of Leases | - | - | - | - | - | 0.2 |
Current Income Taxes Payable | 29.55 | 18.51 | 23.41 | 16.56 | 18.5 | 15.32 |
Current Unearned Revenue | 14.15 | 11.28 | 21.26 | 19.55 | 55.03 | 34.87 |
Other Current Liabilities | 386.04 | 40.32 | 165.37 | 186.08 | 199.29 | 56.78 |
Total Current Liabilities | 1,188 | 958.12 | 1,275 | 1,264 | 1,309 | 898.34 |
Long-Term Debt | 1,083 | 1,258 | 1,054 | 923.27 | - | - |
Long-Term Unearned Revenue | 34.19 | 37.81 | 30.33 | 42.52 | 63.6 | 68.86 |
Long-Term Deferred Tax Liabilities | 39 | 38.77 | 34.99 | 44.66 | 0.37 | 0.06 |
Other Long-Term Liabilities | - | - | - | 93.33 | 186.66 | 279.99 |
Total Liabilities | 2,345 | 2,293 | 2,394 | 2,367 | 1,560 | 1,247 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 544.82 | 543.47 | 543.47 | 551.01 | 551.01 | 551.01 |
Additional Paid-In Capital | - | - | - | - | - | 2 |
Retained Earnings | 2,846 | 2,740 | 2,497 | 2,226 | 2,111 | 1,830 |
Treasury Stock | - | - | -26.86 | -140.42 | -53.72 | -100 |
Comprehensive Income & Other | 220.16 | 205.5 | 204.58 | 256.07 | -36.37 | - |
Total Common Equity | 3,611 | 3,489 | 3,218 | 2,893 | 2,572 | 2,283 |
Minority Interest | -0.01 | -0.01 | -0 | - | - | - |
Shareholders' Equity | 3,611 | 3,489 | 3,218 | 2,893 | 2,572 | 2,283 |
Total Liabilities & Equity | 5,956 | 5,782 | 5,613 | 5,261 | 4,132 | 3,530 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,516 | 1,749 | 1,715 | 1,586 | 532.39 | 414.57 |
Net Cash (Debt) | -133.22 | -415.78 | -290.5 | -83.59 | 22.52 | 87.93 |
Net Cash Growth | - | - | - | - | -74.39% | -92.15% |
Net Cash Per Share | -0.22 | -0.70 | -0.49 | -0.14 | 0.04 | 0.16 |
Filing Date Shares Outstanding | 544.82 | 543.69 | 534.68 | 542.23 | 559.82 | 543.33 |
Total Common Shares Outstanding | 544.82 | 543.69 | 534.68 | 542.23 | 559.82 | 543.33 |
Working Capital | 1,260 | 1,458 | 1,195 | 1,198 | 77.97 | 213.04 |
Book Value Per Share | 6.63 | 6.42 | 6.02 | 5.34 | 4.59 | 4.20 |
Tangible Book Value | 3,376 | 3,275 | 3,036 | 2,721 | 2,406 | 2,117 |
Tangible Book Value Per Share | 6.20 | 6.02 | 5.68 | 5.02 | 4.30 | 3.90 |
Buildings | - | 1,506 | 1,473 | 1,377 | 1,180 | 490.73 |
Machinery | - | 1,267 | 1,149 | 938.79 | 844.74 | 360.6 |
Construction In Progress | - | 872.14 | 661.13 | 504.59 | 672.13 | 1,479 |